Shares of Eli Lilly & Co (NYSE: LLY) are in the red this morning after the pharmaceutical giant reported weaker-than-expected results for its fiscal second quarter. Key takeaways from Eli Lilly Q2 res
INDIANAPOLIS , Aug. 4, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will now conduct its second-quarter 2022 financial results investor conference call today at 10 a.m. Eastern time due to t
Eli Lilly CEO David Ricks joins CNBC's 'Squawk Box' to react to the pharma company's second-quarter earnings report, which missed Wall Street's estimates.
Lilly (LLY) delivered earnings and revenue surprises of -30.56% and 5.91%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Eli Lilly missed second-quarter expectations and slashed its full-year outlook Thursday, leading LLY stock to crumble. The post Eli Lilly Slashes Guidance After 'Significantly' Missing Quarterly Estim
Eli Lilly & Co. LLY, -1.99% shares fell 3.6% in pre-market trading on Thursday after the company reported second-quarter results that came in below Wall Street's forecast. The company's stock ended We
Eli Lilly and Co reported a 31% fall in quarterly profit on Thursday, hurt by lower prices of diabetes drug Humalog and Insulin Lispro injection.
With earnings due, IBD Leaderboard stocks like Eli Lilly, Vertex and Ollie's test bases, breakouts and buy zones. The post Watch These Leaders With Earnings Due, Buy Zones In Focus appeared first on I

AbbVie (ABBV) Q2 Earnings Beat Estimates

01:05pm, Friday, 29'th Jul 2022 Zacks Investment Research
AbbVie (ABBV) delivered earnings and revenue surprises of 1.81% and 0.48%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

10 Biggest Companies Reporting Q2 Earnings Next Week

05:12am, Friday, 29'th Jul 2022 Investing.com

Eli Lilly (LLY) Gains But Lags Market: What You Should Know

09:45pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Eli Lilly (LLY) closed at $330.80 in the latest trading session, marking a +0.57% move from the prior day.

Sanofi (SNY) Q2 Earnings & Sales Beat, Ups 2022 Growth View

04:11pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Sanofi (SNY) beats second-quarter estimates for earnings and sales. Dupixent drives sales growth and a strong recovery in travel vaccines. The company raises its earnings growth guidance for 2022.

Earnings Preview: Eli Lilly (LLY) Q2 Earnings Expected to Decline

02:02pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
If you are patient enough, the payoff will be well worth it.
Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE